Combo of SGLT2 Inhibitor + GLP-1 RA Boosts Diabetes Survival

Survival of patients with type 2 diabetes and CVD rose by 80% when they received both an SGLT2 inhibitor and GLP-1 RA, compared with either class alone.

Related Keywords

Houston ,Texas ,United States ,New York ,Morningside ,Washington ,Baylor College Of Medicine ,Salims Virani ,Persiod Lopez , ,Us Veterans Affairs ,National Va Database ,American College Of Cardiology ,Michaele Debakey Va Medical Center ,Jamesj Peters Va Medical Center ,American College ,Mount Sinai Morningside ,Hard To Control Diabetes ,Baylor College ,Diabetes Mellitus Type 2 ,Iabetes Mellitus Type Ii ,Type 2 Diabetes ,Diabetes Mellitus ,Sglt2 Inhibitors ,Odium Glucose Transporter 2 Inhibitors ,Odium Glucose Co Transporter 2 Inhibitors ,Sodium Glucose Cotransporter 2 Inhibitors ,Acute Coronary Syndrome Acs ,Cute Coronary Syndrome ,Cs ,Atherosclerotic Heart Disease ,Therosclerotic Cardiovascular Disease ,Oronary Heart Disease ,Schemic Hear ,